Literature DB >> 17526921

Bisphosphonates in the renal patient.

John Cunningham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17526921     DOI： 10.1093/ndt/gfm217

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  6 in total

1.  Temporal trends in fracture rates and postdischarge outcomes among hemodialysis patients.

Authors:  Anne C Beaubrun; Ryan D Kilpatrick; Janet K Freburger; Brian D Bradbury; Lily Wang; M Alan Brookhart
Journal:  J Am Soc Nephrol       Date:  2013-06-06       Impact factor: 10.121

2.  Bisphosphonates and bone fractures in long-term kidney transplant recipients.

Authors:  Emily Conley; Brenda Muth; Millie Samaniego; Mary Lotfi; Barbara Voss; Mike Armbrust; John Pirsch; Arjang Djamali
Journal:  Transplantation       Date:  2008-07-27       Impact factor: 4.939

Review 3.  Bisphophonates in CKD patients with low bone mineral density.

Authors:  Wen-Chih Liu; Jen-Fen Yen; Cheng-Lin Lang; Ming-Tso Yan; Kuo-Cheng Lu
Journal:  ScientificWorldJournal       Date:  2013-12-31

4.  Alendronate as an effective treatment for bone loss and vascular calcification in kidney transplant recipients.

Authors:  Masanori Okamoto; Shintaro Yamanaka; Wataru Yoshimoto; Takashi Shigematsu
Journal:  J Transplant       Date:  2014-02-19

Review 5.  Cardiovascular Calcification in Chronic Kidney Disease-Therapeutic Opportunities.

Authors:  Anika Himmelsbach; Carina Ciliox; Claudia Goettsch
Journal:  Toxins (Basel)       Date:  2020-03-14       Impact factor: 4.546

6.  Effect of vitamin D therapy on bone mineral density in patients with diabetic nephropathy; a randomized, double-blind placebo controlled clinical trial.

Authors:  Gayani Liyanage; Sarath Lekamwasam; Thilak Weerarathna; Chandrani Liyanage
Journal:  J Diabetes Metab Disord       Date:  2021-01-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.